Eleven Biotherapeutics reported $116.1M in Market Capitalization this March of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Amgen AMGN:US $ 129.08B 2.36B
Bayer BAYN:GR 61.51B 15.23B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Corcept Therapeutics CORT:US $ 2.39B 0.1B
Eleven Biotherapeutics EBIO:US $ 0.12B 0.04B
Eli Lilly And LLY:US $ 272.72B 8.49B
Intrexon XON:US $ 0.44B 0.33B
Merk MRK:US $ 207.45B 13.86B
Pfizer PFE:US $ 292.38B 39.06B
Rigel Pharmaceuticals RIGL:US $ 0.51B 0.06B
Roche Holding ROG:VX 300.5B 1.25B
X T L Biopharmaceuticals XTLB:US 0.02B 0B
Ziopharm Oncology ZIOP:US $ 0.14B 0.1B